Novartis' Zortress Patent Survives PTAB Challenge
While certain claims in a Novartis AG patent for its immunosuppressant Zortress probably could have been found by other chemists based on existing knowledge, the chances were so small that the...To view the full article, register now.
Already a subscriber? Click here to view full article